Document Detail


Comparative randomised clinical study of tolerability and efficacy of Rhinomer Force 3 versus a reference product in post-operative care of the nasal fossae after endonasal surgery.
MedLine Citation:
PMID:  8736053     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Twenty-eight patients undergoing rhinologic surgery were enrolled in a clinical study to compare two post-operative cleansing preparations. Patients were asked to wash their nasal fossae for 1 month, either with Rhinomer, a cleansing preparation of isotonic, sterile, undiluted sea water, presented in slightly pressurised bottle with neither CFC nor preservative, or with Prorhinel, a marketed solution containing an antiseptic agent. Patients were randomly allocated to treatment beginning 2 days after surgery. Nasal status was assessed by symptoms (blocking nose, rhinorrhoea, sneezing, itching and impaired smell) and rhinologic endoscopy (colour of the nasal mucosa, swelling of the mucosa, secretions, presence of crusts or pus). Patients attended control visits on days 9, 15 and 30 following surgery. They were asked to record symptom intensity and use of a rescue medication (Vibrocil, dimetindene 0.25 mg and phenylephrine 2.5 mg/ml) on a diary card. Twenty-six of 28 patients were eligible for efficacy analysis, 14 in the Rhinomer group and 12 in the Prorhinel group, In both groups, intensity of complaints decreased markedly over the study period. No severe adverse drug reactions were reported in either treatment. Evoked complaint frequency was comparable between groups, but patient's and physician's opinion on tolerability was significantly different between treatments, in favour of Rhinomer. In addition, the test preparation was found to be easier to use than Prorhinel. The weekly average frequency of use of the rescue medication was not significantly different between treatments. When both patients and physicians were asked about treatment efficacy, they expressed an opinion significantly more favourable to Rhinomer than to the reference drug. In this study, Rhinomer has shown efficacious results that justify its use in washing of the nasal cavities following endonasal surgery.
Authors:
M Seppey; T Schweri; R Häusler
Related Documents :
16550943 - Severe nasal polyposis and its impact on quality of life. the effect of a short course ...
19626333 - The effects of phototherapy on quality of life in allergic rhinitis cases.
10796403 - Patient education for mechanical neck disorders.
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  ORL; journal for oto-rhino-laryngology and its related specialties     Volume:  58     ISSN:  0301-1569     ISO Abbreviation:  ORL J. Otorhinolaryngol. Relat. Spec.     Publication Date:    1996 Mar-Apr
Date Detail:
Created Date:  1996-11-12     Completed Date:  1996-11-12     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0334721     Medline TA:  ORL J Otorhinolaryngol Relat Spec     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  87-92     Citation Subset:  IM    
Affiliation:
Rhinology Unit, Inselspital Bern, Switzerland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Anti-Infective Agents, Local / administration & dosage
Benzalkonium Compounds / administration & dosage
Endoscopy*
Female
Humans
Irrigation
Male
Middle Aged
Nose Diseases / surgery*
Postoperative Care
Postoperative Complications / therapy*
Seawater*
Treatment Outcome
Chemical
Reg. No./Substance:
0/Anti-Infective Agents, Local; 0/Benzalkonium Compounds; 10328-35-5/dimethyldodecylbenzylammonium

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Distribution of eosinophil granule proteins in nasal mucosa of atopic patients with nasal polyposis.
Next Document:  Diagnostic and prognostic value of nucleolar organizer regions in squamous-cell carcinomas of the ma...